Learn About Chronic Polyradiculoneuritis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Vickie & Jack Farber Institute For Neuroscience - Honickman Center
Marinos Dalakas is a Neurologist and a Neuromusculoskeletal Medicine provider in Philadelphia, Pennsylvania. Dr. Dalakas is rated as an Elite provider by MediFind in the treatment of Chronic Polyradiculoneuritis. His top areas of expertise are Stiff Person Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, Hereditary Hyperekplexia, Chronic Polyradiculoneuritis, and Laminectomy. Dr. Dalakas is currently accepting new patients.
New Jersey Pediatric Neuroscience Institute
Nizar Souayah is a Neurologist in Hackensack, New Jersey. Dr. Souayah is rated as an Elite provider by MediFind in the treatment of Chronic Polyradiculoneuritis. His top areas of expertise are Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barre Syndrome, Myasthenia Gravis, and Chronic Polyradiculoneuritis. Dr. Souayah is currently accepting new patients.
Eduardo Orazio-Nobile practices in Milan, Italy. Mr. Orazio-Nobile is rated as an Elite expert by MediFind in the treatment of Chronic Polyradiculoneuritis. His top areas of expertise are Chronic Demyelinizing Neuropathy with IgM Monoclonal, Chronic Polyradiculoneuritis, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy.
Summary: The purpose of this Phase 3 study is to demonstrate the efficacy of DNTH103 as compared to placebo in participants with chronic inflammatory demyelinating polyneuropathy (CIDP).
Summary: The purpose of the study is to evaluate efficacy of riliprubart compared to IVIg in adult participants with CIDP who are receiving maintenance treatment with IVIg. The study duration will be for a maximum of 109 weeks including screening, treatment phases, and follow-up.